Publication | Closed Access

A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade

Predictive ModelTumor CellularityCancer ImmunosurveillanceBreast OncologyMedicineImmunologyImmunoeditingImmune Checkpoint InhibitorBreast CancerCancer TreatmentOncologyCell BiologyTumor MicroenvironmentTumor BiologyHer2-positive Breast Cancer